⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL48682 | 1.00 | — | — | |
| SCHEMBL17183 | 1.00 | — | — | |
| Water SCHEMBL27590110 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL16919 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL221709 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL15018351 | 0.97 | — | — | |
| Methane SCHEMBL17043017 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL322098 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL23163951 | 0.94 | — | — | |
| Ethane SCHEMBL10435359 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070879-A1 | ISOXAZOLINE DERIVATIVES | ELANCO TIERGESUNDHEIT AG (CH) | 2026-03-12 | — | — | US | claimed |
| EP-4532014-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | Cerevance, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2024257116-A1 | NOVEL POLYMORPHIC FORMS OF ASCIMINIB AND ITS PHARMACEUTICAL SALTS THEREOF | NATCO PHARMA LIMITED (IN) | 2024-12-19 | — | — | WO | claimed |
| WO-2023227867-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | Cerevance, Inc. (US) | 2023-11-30 | — | — | WO | claimed |
| CN-116535397-A | Isobenzofuran-1 (3H) -one compound, preparation method, pharmaceutical composition and application thereof | 中国医学科学院药物研究所 | 2023-08-04 | — | — | CN | claimed |
| EP-4211116-A1 | NOVEL HETEROCYCLIC ANTIBIOTICS | F. Hoffmann-La Roche AG (CH) | 2023-07-19 | — | — | EP | claimed |
| CN-116283700-A | Preparation method of 1-R-3-pyrrolidinol | 江苏倍合德医药科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-113493628-B | Quantum dot ink and preparation method of quantum dot film | TCL科技集团股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| WO-2022049272-A1 | NOVEL HETEROCYCLIC ANTIBIOTICS | F. HOFFMANN-LA ROCHE AG (CH) | 2022-03-10 | — | — | WO | claimed |
| CN-113493628-A | Quantum dot ink and preparation method of quantum dot film | TCL科技集团股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| WO-2005016242-A2 | SYNTHETIC PROCESS FOR TRANS-AMINOCYCLOHEXYL ETHER COMPOUNDS | CARDIOME PHARMA CORP. (CA) | 2005-02-24 | — | — | WO | claimed |
| US-20050038256-A1 | Synthetic process for trans-aminocyclohexyl ether compounds | CARDIOME PHARMA CORP. (CA) | 2005-02-17 | — | — | US | claimed |
| US-6344566-B1 | AMIDATION AND REDUCTION AND CONVERSION WITH ACID; ASIMADOLINE | MERCK PATENT GMBH (DE) | 2002-02-05 | — | — | US | claimed |
| EP-0877298-B1 | Coated xerographic photographic paper | XEROX CORP (US) | 2001-08-29 | — | — | EP | claimed |
| US-6096443-A | Transparencies | XEROX CORPORATION (US) | 2000-08-01 | — | — | US | claimed |
| US-5612371-A | ENZYME INHIBITORS | SOCIETE CIVILE BIOPROJECT (FR) | 1997-03-18 | — | — | US | claimed |
| EP-0331960-B1 | Process for the preparation of enantiomerically homogeneous aminopyrrolidinyl naphthyridine and quinolone carboxylic acids | ABBOTT LAB (US) | 1994-05-18 | — | — | EP | claimed |
| US-4956475-A | REDUCTIVE ACETYLATION OF THE 3-AZIDO DERIVATIVE USING THIOACETIC ACID TO OBTAIN THE CORRESPONDING ACETAMIDE | ABBOTT LABORATORIES (US) | 1990-09-11 | — | — | US | claimed |
| EP-0331960-A2 | Process for the preparation of enantiomerically homogeneous aminopyrrolidinyl naphthyridine and quinolone carboxylic acids | ABBOTT LABORATORIES (US) | 1989-09-13 | — | — | EP | claimed |
| US-4859776-A | (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation | ABBOTT LABORATORIES (US) | 1989-08-22 | — | — | US | claimed |